FI970331L - Läkemedlets administreringskomposition för nasal administrering - Google Patents

Läkemedlets administreringskomposition för nasal administrering Download PDF

Info

Publication number
FI970331L
FI970331L FI970331A FI970331A FI970331L FI 970331 L FI970331 L FI 970331L FI 970331 A FI970331 A FI 970331A FI 970331 A FI970331 A FI 970331A FI 970331 L FI970331 L FI 970331L
Authority
FI
Finland
Prior art keywords
antiviral agents
nasal administration
delivery composition
pharmaceutical delivery
pharmaceutical
Prior art date
Application number
FI970331A
Other languages
English (en)
Finnish (fi)
Other versions
FI970331A7 (sv
FI970331A0 (sv
Inventor
Peter Watts
Lisbeth Illum
Original Assignee
Danbiosyst Uk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danbiosyst Uk filed Critical Danbiosyst Uk
Publication of FI970331A7 publication Critical patent/FI970331A7/sv
Publication of FI970331L publication Critical patent/FI970331L/sv
Publication of FI970331A0 publication Critical patent/FI970331A0/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1774—Immunoglobulin superfamily (e.g. CD2, CD4, CD8, ICAM molecules, B7 molecules, Fc-receptors, MHC-molecules)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Otolaryngology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Tires In General (AREA)
  • Tyre Moulding (AREA)
FI970331A 1994-07-26 1995-07-24 Läkemedlets administreringskomposition för nasal administrering FI970331A0 (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9414966A GB9414966D0 (en) 1994-07-26 1994-07-26 Pharmaceutical compositions for the nasal administration of antiviral agents
PCT/GB1995/001735 WO1996003142A1 (en) 1994-07-26 1995-07-24 Drug delivery composition for the nasal administration of antiviral agents

Publications (3)

Publication Number Publication Date
FI970331A7 FI970331A7 (sv) 1997-01-27
FI970331L true FI970331L (sv) 1997-01-27
FI970331A0 FI970331A0 (sv) 1997-01-27

Family

ID=10758832

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970331A FI970331A0 (sv) 1994-07-26 1995-07-24 Läkemedlets administreringskomposition för nasal administrering

Country Status (7)

Country Link
EP (1) EP0773791A1 (sv)
JP (1) JPH10506376A (sv)
CA (1) CA2195639A1 (sv)
FI (1) FI970331A0 (sv)
GB (2) GB9414966D0 (sv)
NO (1) NO970252D0 (sv)
WO (1) WO1996003142A1 (sv)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68929096T2 (de) 1988-09-01 2000-05-11 Bayer Corp., Pittsburgh Menschliches Rhinovirusrezeptorprotein, das die Virusinfektionsanfälligkeit hemmt
US5879712A (en) 1995-06-07 1999-03-09 Sri International Method for producing drug-loaded microparticles and an ICAM-1 dosage form so produced
US6365343B1 (en) * 1996-03-06 2002-04-02 Boehringer Ingelheim Pharmaceuticals, Inc. Intercellular adhesion molecule powder formulation
GB9700624D0 (en) * 1997-01-14 1997-03-05 Danbiosyst Uk Drug delivery composition
GB9707934D0 (en) * 1997-04-18 1997-06-04 Danbiosyst Uk Improved delivery of drugs to mucosal surfaces
US6391452B1 (en) 1997-07-18 2002-05-21 Bayer Corporation Compositions for nasal drug delivery, methods of making same, and methods of removing residual solvent from pharmaceutical preparations
WO1999003452A1 (en) * 1997-07-18 1999-01-28 Bayer Corporation Methods of removing residual solvent from nasal drug delivery compositions
CA2308291A1 (en) * 1997-10-31 1999-05-14 Thierry Nivaggioli Controlled release compositions comprising gellan gum gels
DK1035833T3 (da) * 1997-12-02 2006-01-09 Archimedes Dev Ltd Sammensætning til nasal indgivelse
GB0015682D0 (en) * 2000-06-28 2000-08-16 Bristol Myers Squibb Co Sprayable wound care composition
RU2185822C2 (ru) * 2000-08-01 2002-07-27 Общество с ограниченной ответственностью "Фармаген" Препарат для лечения и профилактики вирусных заболеваний
GB2378383A (en) * 2001-06-06 2003-02-12 Gursharan Moonga Nasal delivery of pharmaceutical compositions in powder form
GB0300531D0 (en) 2003-01-10 2003-02-12 West Pharm Serv Drug Res Ltd Pharmaceutical compositions
GB0328186D0 (en) 2003-12-05 2004-01-07 West Pharm Serv Drug Res Ltd Intranasal compositions
GB0403938D0 (en) * 2004-02-21 2004-03-24 West Pharm Serv Drug Res Ltd Chitosan containing solution
WO2008091592A1 (en) 2007-01-22 2008-07-31 Targacept, Inc. Intranasal, buccal, and sublingual administration of metanicotine analogs
DE102008007759B4 (de) 2007-12-04 2009-09-24 Atlantichem Gmbh Mittel zum Verhindern von Verfärbungen beim Waschen von Textilien

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946870A (en) * 1986-06-06 1990-08-07 Union Carbide Chemicals And Plastics Company Inc. Delivery systems for pharmaceutical or therapeutic actives
ES2064327T3 (es) * 1987-11-02 1995-02-01 Baylor College Medicine Uso de icam-1 o de sus derivados funcionales para el tratamiento de una inflamacion no especifica.
DE68929096T2 (de) * 1988-09-01 2000-05-11 Bayer Corp., Pittsburgh Menschliches Rhinovirusrezeptorprotein, das die Virusinfektionsanfälligkeit hemmt
SE8804164A0 (sv) * 1988-11-17 1990-05-18 Per Prisell Farmaceutisk beredning
GB2237510B (en) * 1989-11-04 1993-09-15 Danbiosyst Uk Small particle drug compositions for nasal administration
WO1993006842A1 (en) * 1991-10-02 1993-04-15 Boehringer Ingelheim Pharmaceuticals, Inc. Use of intercellular adhesion molecules, and their binding ligands in the treatment of asthma
EP0604624A4 (en) * 1992-06-22 1997-03-12 Miles Inc MULTIMERE FORMS OF HUMAN RHINOVIRUS RECEPTOR PROTEIN.
GB9310412D0 (en) * 1993-05-20 1993-07-07 Danbiosyst Uk Nasal nicotine system

Also Published As

Publication number Publication date
GB9414966D0 (en) 1994-09-14
NO970252L (no) 1997-01-21
EP0773791A1 (en) 1997-05-21
FI970331A7 (sv) 1997-01-27
GB2305606A (en) 1997-04-16
AU707462B2 (en) 1999-07-08
GB2305606B (en) 1998-08-05
AU2988695A (en) 1996-02-22
WO1996003142A1 (en) 1996-02-08
FI970331A0 (sv) 1997-01-27
CA2195639A1 (en) 1996-02-08
JPH10506376A (ja) 1998-06-23
NO970252D0 (no) 1997-01-21
GB9700817D0 (en) 1997-03-05

Similar Documents

Publication Publication Date Title
NO20002851D0 (no) Blandinger for nasal administrasjon av medikamenter
MX9101175A (es) Composicion farmaceutica para administracion nasal
FI955583A7 (sv) Nasal, nicotin innehållande distributionskomposition för läkemedel
FI970331L (sv) Läkemedlets administreringskomposition för nasal administrering
GB2303064B (en) Medicament for nasal administration
ITMI910436A0 (it) Erogatore nasale di sostanze farmaceutiche nebulizzate
HRP960300B1 (en) Inhaler for administration of blister-packed medicaments
NO20003161D0 (no) Blandinger for nasal administrasjon av kannabinoider
FI944123L (sv) Farmaceutiska inhalationssammansättningar
FI972579L (sv) Intravaginala läkemedelstillförselsanordningar för givande av 17 beta-estradiolprekursorer
FI980822A7 (sv) Farmaceutisk komposition för administrering av en aktiv substans på eller genom hud- eller slemhinnaytan
ITRM910922A1 (it) Composizione farmaceutica anticefalalgica per somministrazione endonasale, procedimento per prepararla e suo impiego terapeutico
IL127572A (en) Pharmaceutical composition and medicament for nasal administration
FI955310L (sv) Farmacertisk komposition för oral administration av flavonoider
NO950134D0 (no) Formuleringer for oralt administrerte farmasöytiske midler
IT9019112A1 (it) Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina
IT1223132B (it) Composizione farmaceutica per somministrazione nasale
ITBS920130A0 (it) Composizione farmaceutiche topiche per le allergie respiratorie
ITMI913306A0 (it) Composizioni farmaceutiche per la somministrazione nasale di polipeptidi
ITMI940562A0 (it) Composizioni farmaceutiche di calcitonina somministrabili per via rettale
IT8819541A0 (it) Composizione farmaceutica per somministrazione nasale.
ITMI920214A0 (it) Composizioni farmaceutiche stabili per la somministrazione orale di calcitonina
IT9021264A0 (it) Composizioni farmaceutiche per la somministrazione intranasale di calcitonina
ITPD920141A0 (it) Formulazione farmaceutiche per la somministraziane orale di calcitoni-na
NO920647L (no) Nasalt farmasoeytisk preparat

Legal Events

Date Code Title Description
MA Patent expired